Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rheumatoid Arthritis
|
2387 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.030 | 0.667 | 3 | 2013 | 2017 | |||||
Ewings sarcoma
|
25 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Graves Disease
|
352 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Hepatitis C
|
347 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||
Primary biliary cirrhosis
|
667 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2010 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||
Anemia, Sickle Cell
|
138 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Brucellosis
|
30 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
cervical cancer
|
268 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Cervix carcinoma
|
283 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Childhood Osteosarcoma
|
151 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Chronic kidney disease stage 5
|
194 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Drug-Induced Liver Disease
|
29 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Focal glomerulosclerosis
|
50 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Hashimoto Disease
|
131 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Idiopathic Nephrotic Syndrome
|
72 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Infantile nystagmus syndrome
|
8 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1 | 2019 | 2019 | ||||||
Kidney Failure, Chronic
|
425 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Latent Autoimmune Diabetes in Adults
|
12 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Latent autoimmune diabetes mellitus in adult
|
12 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Lipoid nephrosis
|
3 | 0.614 | 0.680 | 2 | 203867624 | upstream gene variant | C/T | snv | 6.7E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 |